ROR1 and neoplasm: To evaluate the ability of 22.0405.aF to induce NK cell-mediated ADCC against tumor cells that naturally express ROR1, NK cytotoxicity assays were performed using JeKo-1 cells as targets (5–10K ROR1/cell).